Regencell Bioscience Holdings Stock Price on November 27, 2024

RGC Stock  USD 6.32  0.33  5.51%   
If you're considering investing in Regencell Stock, it is important to understand the factors that can impact its price. As of today, the current price of Regencell Bioscience stands at 6.32, as last reported on the 1st of December, with the highest price reaching 6.32 and the lowest price hitting 5.81 during the day. Regencell Bioscience appears to be very risky, given 3 months investment horizon. Regencell Bioscience maintains Sharpe Ratio (i.e., Efficiency) of 0.0361, which implies the firm had a 0.0361% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Regencell Bioscience, which you can use to evaluate the volatility of the company. Please evaluate Regencell Bioscience's Semi Deviation of 6.48, risk adjusted performance of 0.0123, and Coefficient Of Variation of 24364.1 to confirm if our risk estimates are consistent with your expectations.
  
The current year's Total Stockholder Equity is expected to grow to about 8.6 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 11.1 M. . At present, Regencell Bioscience's Price To Operating Cash Flows Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price To Free Cash Flows Ratio is expected to grow to 10.29, whereas Price To Sales Ratio is forecasted to decline to 0.36. Regencell Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0361

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsRGC
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 9.37
  actual daily
83
83% of assets are less volatile

Expected Return

 0.34
  actual daily
6
94% of assets have higher returns

Risk-Adjusted Return

 0.04
  actual daily
2
98% of assets perform better
Based on monthly moving average Regencell Bioscience is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regencell Bioscience by adding it to a well-diversified portfolio.
Price Book
10.0066
Book Value
0.632
Enterprise Value
74.4 M
Enterprise Value Ebitda
(44.58)
Shares Float
1.4 M

Regencell Bioscience Main Headline on 27th of November 2024

Regencell Bioscience Holdings Ltd , a company specializing in traditional Chinese medicine for neurological and cognitive disorders, experienced a signific

Regencell Bioscience Valuation on November 27, 2024

It is possible to determine the worth of Regencell Bioscience on a given historical date. On November 27, 2024 Regencell was worth 6.12 at the beginning of the trading date compared to the closed value of 5.99. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Regencell Bioscience stock. Still, in general, we apply an absolute valuation method to find Regencell Bioscience's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Regencell Bioscience where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Regencell Bioscience's related companies.
 Open High Low Close Volume
  5.90    6.31    5.90    6.10    42,840  
11/27/2024
  6.12    6.16    5.72    5.99    13,042  
  6.00    6.32    5.81    6.32    107,921  
Backtest Regencell Bioscience  |  Regencell Bioscience History  |  Regencell Bioscience Valuation   PreviousNext  
Open Value
6.12
5.99
Closing Value
34.22
Upside

Regencell Bioscience Trading Date Momentum on November 27, 2024

On November 29 2024 Regencell Bioscience Holdings was traded for  6.32  at the closing time. Highest Regencell Bioscience's price during the trading hours was 6.32  and the lowest price during the day was  5.81 . The net volume was 107.9 K. The overall trading history on the 29th of November contributed to the next trading period price growth. The trading delta at closing time to the next next day price was 5.51% . The trading delta at closing time to current price is 0.17% .

Regencell Bioscience Fundamentals Correlations and Trends

By evaluating Regencell Bioscience's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Regencell Bioscience's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Regencell financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Regencell Bioscience Stock history

Regencell Bioscience investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Regencell is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Regencell Bioscience will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Regencell Bioscience stock prices may prove useful in developing a viable investing in Regencell Bioscience
Last ReportedProjected for Next Year
Common Stock Shares Outstanding11.7 M11.1 M
Net Loss-6.7 M-6.4 M

Regencell Bioscience Stock Technical Analysis

Regencell Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Regencell Bioscience technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Regencell Bioscience trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Regencell Bioscience Period Price Range

Low
December 1, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Regencell Bioscience Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Regencell Bioscience December 1, 2024 Market Strength

Market strength indicators help investors to evaluate how Regencell Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regencell Bioscience shares will generate the highest return on investment. By undertsting and applying Regencell Bioscience stock market strength indicators, traders can identify Regencell Bioscience Holdings entry and exit signals to maximize returns

Regencell Bioscience Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Regencell Bioscience's price direction in advance. Along with the technical and fundamental analysis of Regencell Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Regencell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Regencell Stock analysis

When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities